Release Date: 21/02/13 12:46 Summary: Corporate Fact Sheet Price Sensitive: No Download Document 438.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%